PHARMAID · PHARMAIDS PHARMACEUTICALS LTD. · Financials
Market Cap
1.01B INR
Shares
35.27M
Volume · Nov 13
4022
Avg daily vol (3M)
4191
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
278.82M
+43.4%
FY2026
Net Income
-117.17M
-8.7%
FY2026
Operating Cash Flow
-40.57M
+71%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 210.71M | 278.82M | 194.47M |
| INR | 19.29M | 20.27M | 24.4M |
| INR | 26.27M | 34.92M | 20.88M |
| INR | -54.36M | -163.03M | -172.79M |
| INR | -17.68M | -47.31M | -37.74M |
| INR | -41.83M | -117.17M | -107.77M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.